comparemela.com

Latest Breaking News On - Garrett investment advisors - Page 5 : comparemela.com

Keene & Associates Inc Takes $3 02 Million Position in Intel Co (NASDAQ:INTC)

Keene & Associates Inc. acquired a new stake in shares of Intel Co. (NASDAQ:INTC – Get Rating) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 58,693 shares of the chip maker’s stock, valued at approximately $3,023,000. Intel comprises approximately 2.6% […]

Roku (NASDAQ:ROKU) Trading Up 5 1%

Shares of Roku, Inc. (NASDAQ:ROKU – Get Rating) were up 5.1% during mid-day trading on Monday . The company traded as high as $132.02 and last traded at $132.02. Approximately 1,125 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 7,580,384 shares. The stock had previously closed at […]

Fortune Brands Home & Security (NYSE:FBHS) Reaches New 1-Year Low at $72 04

Fortune Brands Home & Security, Inc. (NYSE:FBHS – Get Rating)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $72.04 and last traded at $72.24, with a volume of 17318 shares changing hands. The stock had previously closed at $74.65. A number of research analysts […]

BlackRock (NYSE:BLK) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of BlackRock (NYSE:BLK – Get Rating) from a sell rating to a hold rating in a research note published on Monday, Zacks.com reports. They currently have $808.00 price target on the asset manager’s stock. According to Zacks, “Shares of BlackRock have underperformed the industry over the past year. The company […]

Deutsche Bank Aktiengesellschaft Lowers CVS Health (NYSE:CVS) to Hold

Deutsche Bank Aktiengesellschaft lowered shares of CVS Health (NYSE:CVS – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Marketbeat Ratings reports. Deutsche Bank Aktiengesellschaft currently has $110.00 price objective on the pharmacy operator’s stock. Several other research analysts have also weighed in on the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.